Indian equity markets are expected to open on a cautious note on Thursday, tracking mixed global cues and stock-specific action driven by quarterly earnings and key corporate developments.
Several companies are scheduled to announce their quarterly results today, including Elecon Engineering Company, Eimco Elecon (India), REC Ltd, Yuranus Infrastructure, and Toyam Sports, which are likely to remain in focus during the trading session.
Global Market Cues
Overnight, US markets delivered a mixed performance. Dow Jones futures traded marginally higher at 49,066.68, while the S&P 500 declined 0.34 percent. The Nasdaq ended slightly higher, indicating selective buying in technology stocks.
Asian markets largely traded in the red during early hours. GIFT Nifty slipped 0.15 percent, signalling a subdued start for domestic indices. Japan’s Nikkei 225 declined over 0.7 percent, while Hang Seng fell nearly 1 percent. Shanghai Composite, however, traded marginally higher.
Corporate Developments
Fortis Healthcare announced that it will hold investor and analyst meetings in New York and Boston between January 12 and 13, organised by J.P. Morgan. The company will also participate in the J.P. Morgan 2026 Healthcare Conference in San Francisco on January 15. The meetings will focus on general business updates and sectoral trends.
Shares of Granules India are expected to attract attention after its wholly owned US subsidiary, Granules Pharmaceuticals Inc., received Tentative Approval from the USFDA for its generic Amphetamine Extended-Release Tablets, used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
The product is eligible for a 180-day exclusivity period in the US market and addresses an estimated market size of USD 41 million. This marks the second consecutive tentative approval for the company in recent weeks, strengthening its position in the central nervous system (CNS) therapeutic segment and its complex generics portfolio.
